Related Experiment Videos
NTAKalpha and beta isoforms stimulate breast tumor cell growth by means of different receptor combinations
N Nakano1, S Higashiyama, K Kajihara
1Department of Biochemistry, Room B-Osaka University Medical School, Yamadaoka, Suita, Osaka 565-0871, Japan.
Abstract:
Neural- and thymus-derived activator for ErbB kinases (NTAK) is a recently described member of the neuregulin family that binds directly to ErbB3 and ErbB4 and transactivates ErbB2. Rat NTAK has at least five alternative-spliced isoforms: alpha1, alpha2a, alpha2b, beta, and gamma. In order to understand their biological properties, this study focused on the NTAK alpha2a and beta isoforms, which have different EGF-like domains. The effect of these isoforms on cell growth and tyrosine phosphorylation in human breast cancer cells, MDA-MB-453 and T47D, was examined using the recombinant proteins. In terms of cell growth, NTAKalpha2a and NTAKbeta preferentially stimulate T47D cells and MDA-MB-453 cells, respectively, in a dose-dependent manner. Although both NTAKs induce the highest level of tyrosine phosphorylation of ErbB2, NTAKalpha2a and NTAKbeta preferentially induce ErbB3 and ErbB4 phosphorylation, respectively. Thus, NTAKalpha2a and NTAKbeta stimulate cell growth in different ways, by means of different combinations of receptors.
Insights
Neural- and thymus-derived activator for ErbB kinases (NTAK) isoforms alpha2a and beta differentially regulate breast cancer cell growth and ErbB receptor phosphorylation, highlighting distinct biological roles.
Area of Science:
- Molecular biology
- Cell signaling
- Cancer research
Background:
- Neuregulin family members, including Neural- and thymus-derived activator for ErbB kinases (NTAK), play crucial roles in cell signaling.
- NTAK interacts with ErbB3 and ErbB4 receptors and activates ErbB2, suggesting involvement in cancer progression.
- Alternative splicing generates multiple NTAK isoforms with potentially distinct functions.
Purpose of the Study:
- To investigate the distinct biological properties of NTAK alpha2a and NTAK beta isoforms.
- To determine the effects of NTAK alpha2a and NTAK beta on cell growth and tyrosine phosphorylation in human breast cancer cell lines.
- To elucidate the specific ErbB receptor interactions and downstream signaling mediated by these NTAK isoforms.
Main Methods:
- Utilized recombinant proteins of NTAK alpha2a and NTAK beta isoforms.
- Examined the impact on cell growth in MDA-MB-453 and T47D human breast cancer cells.
- Assessed tyrosine phosphorylation levels of ErbB2, ErbB3, and ErbB4 receptors.
Main Results:
- NTAK alpha2a and NTAK beta demonstrated differential effects on cell growth, preferentially stimulating T47D and MDA-MB-453 cells, respectively, in a dose-dependent manner.
- Both isoforms induced significant tyrosine phosphorylation of ErbB2.
- NTAK alpha2a preferentially induced ErbB3 phosphorylation, while NTAK beta preferentially induced ErbB4 phosphorylation.
Conclusions:
- NTAK alpha2a and NTAK beta isoforms exhibit distinct mechanisms in stimulating breast cancer cell growth.
- These isoforms differentially activate specific ErbB receptor combinations (ErbB3 for alpha2a, ErbB4 for beta) to mediate their effects.
- Understanding isoform-specific functions is critical for comprehending NTAK's role in cancer and for developing targeted therapies.